Internal Medicine, Pulmonary Disease · Arecibo, PR
NPI
1972572782
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
51 Calle Gautier Benitez
Arecibo, PR, 00612
Phone (787) 880-1020
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
159 services
Medicare patients, 2024
38
Average age 78
Drug cost, 2024
$4.0M
12,295 prescriptions
Company payments, 2025
$361
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos N Montalvo Bonilla was code 99213 (office e&m - established), 31 times for 20 patients. In total Carlos N Montalvo Bonilla billed 159 services in 10 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 31 | 20 | $57.41 | $1,780 |
| 94060 Pulmonary Function Testing | Office | 26 | 17 | $26.71 | $694 |
| 99222 Hospital E&M - Initial | Facility | 16 | 15 | $93.46 | $1,495 |
By year: 2022 $15K for 185 services; 2023 $14K for 155 services; 2024 $12K for 159 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos N Montalvo Bonilla prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,670 prescriptions and refills. In total Carlos N Montalvo Bonilla wrote 12,295 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,670 | 1,702 | 291 | $1.1M |
| Breo Ellipta Fluticasone/Vilanterol | 1,437 | 1,490 | 318 | $604K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,384 | 1,407 | 609 | $56K |
| Fluticasone Propionate Generic | 1,253 | 1,416 | 343 | $22K |
| Montelukast Sodium Generic | 1,240 | 1,362 | 262 | $9,459 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 897 | 906 | 198 | $443K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 681 | 695 | 164 | $123K |
| Prednisone Generic | 332 | 336 | 105 | $1,445 |
| Azelastine Hcl Generic | 327 | 449 | 116 | $7,738 |
| Spiriva Respimat Tiotropium Bromide | 171 | 174 | 37 | $92K |
| Gabapentin Generic | 139 | 157 | 41 | $793 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 132 | 137 | 40 | $19K |
| Bupropion Hcl Sr Bupropion Hcl | 117 | 127 | 26 | $1,608 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 114 | 120 | 33 | $30K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 95 | 96 | 16 | $45K |
Brand drugs: 6,171 claims; generic drugs: 6,124 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos N Montalvo Bonilla $361 ($361 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $142.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.